Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.

Abstract:

INTRODUCTION:Avoiding intracranial hemorrhage (ICH) during warfarin therapy is critical but little is known about factors that affect warfarin-related ICH outcomes. We aimed to define the impact of warfarin on ICH incidence rates and to identify baseline clinical characteristics of patients who experienced ICH and factors associated with fatal ICH. MATERIALS AND METHODS:The primary outcome of this retrospective cohort study was the incident ICH rate per 10,000 person-years for patients receiving and not receiving warfarin therapy. Cox proportional hazards modeling was used to adjust for potential confounding factors in assessment of the association of warfarin with fatal ICH. RESULTS:A total of 1348 patients with incident ICH, 259 (19%) who were receiving warfarin therapy, were included. The incident ICH rates were 74/10,000 (warfarin) and 5/10,000 (non-warfarin) person-years (p<0.001). Warfarin patients were older and carried a higher burden of chronic disease. The unadjusted hazard ratio (HR) for fatal ICH was 1.64 (95% confidence interval [CI] 1.31-2.05) for warfarin patients compared to non-warfarin patients. However, the HR was no longer significant after adjustment for confounding variables (1.10; 95% CI 0.84-1.42). An INR greater than 3.5 at presentation doubled the adjusted risk for fatal ICH with warfarin therapy. Subarachnoid and subdural ICHs were less likely to be fatal than other ICH types, and each year increase in age was associated with 4% increased risk of fatal ICH. CONCLUSIONS:Although warfarin use increases the rate of incident ICH, other factors impact the risk of fatal ICH, even among anticoagulated patients.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Witt DM,Delate T,Hylek EM,Clark NP,Crowther MA,Dentali F,Ageno W,Martinez KD,Garcia DA

doi

10.1016/j.thromres.2013.10.024

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

770-5

issue

6

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(13)00494-5

journal_volume

132

pub_type

杂志文章
  • A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.

    abstract:BACKGROUND:Acquired von Willebrand Syndrome is a rare bleeding disorder, which arises in individuals with no personal or family history of bleeding, associated with lymphoproliferative and myeloproliferative disorders or other diseases. AIM:To develop a two-step approach assay to detect autoantibodies against VWF and ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.09.020

    authors: Franchi F,Biguzzi E,Stufano F,Siboni SM,Baronciani L,Peyvandi F

    更新日期:2014-12-01 00:00:00

  • Effectiveness of vitamin K in anticoagulation reversal for hip fracture surgery--a prospective observational study.

    abstract:INTRODUCTION:Vitamin K antagonists are often used for anticoagulant treatment in hip fracture patients. The optimal handling with such anticoagulants is unclear. We aimed to determine when anticoagulation reversal occurred after vitamin K administration and how often prothrombin complex concentrates (PCCs) were adminis...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.10.031

    authors: Buecking B,Eschbach D,Bliemel C,Oberkircher L,Struewer J,Ruchholtz S,Sachs UJ

    更新日期:2014-01-01 00:00:00

  • Evidence for the presence of red and white cells within "platelet" aggregates formed in whole-blood.

    abstract::Collagen-induced platelet aggregation and secretion (ATP-release) in whole-blood and platelet-rich plasma was compared. Although the amount of ATP released was comparable in whole-blood and platelet-rich plasma, the maximum extent of aggregation was greater when platelets were studied in their natural milieu, i.e. who...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(89)90203-x

    authors: Joseph R,Welch KM,D'Andrea G,Riddle JM

    更新日期:1989-03-01 00:00:00

  • Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.

    abstract::Venous thromboembolism (VTE) is a common complication in patients with malignant disease. In addition to well-established acquired risk factors for VTE, several genetic risk factors, mainly related to the haemostatic system, are known to influence thrombotic risk. However, the contribution of gene abnormalities to thr...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(03)00179-8

    authors: Ramacciotti E,Wolosker N,Puech-Leao P,Zeratti EA,Gusson PR,del Giglio A,Franco RF

    更新日期:2003-02-15 00:00:00

  • A review of global coagulation assays - Is there a role in thrombosis risk prediction?

    abstract::Normal haemostasis requires maintenance of a careful equilibrium between the necessity to clot when bleeding and the retention of fluid phase at all other times. Disruption of this equilibrium can result in catastrophic outcomes, e.g. acute myocardial infarction and pulmonary embolism. However, despite the significant...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2019.04.033

    authors: Lim HY,O'Malley C,Donnan G,Nandurkar H,Ho P

    更新日期:2019-07-01 00:00:00

  • On the inhibitory effect of chloroquine on blood platelet aggregation.

    abstract::Chloroquine inhibited aggregation of rat blood platelets in a dose-dependent way. The inhibitory effect decreased, depending on the aggregation stimulus used, in the rank order of potency: ADP > thrombin > A23187. Effect of 1 millimolar chloroquine on A23187-stimulated aggregation was significantly decreased or comple...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(94)90270-4

    authors: Jancinová V,Nosál R,Petríková M

    更新日期:1994-06-01 00:00:00

  • The clock gene Per2 is required for normal platelet formation and function.

    abstract:INTRODUCTION:Apoptotic cell death is a highly regulated genetic program, which has been observed in mature megakaryocytes fragmenting into platelets. The clock gene Per2, a key component of core clock oscillator, was involved in affecting both cell cycle control and apoptosis. Thus, loss of Per2 function may be conside...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2010.11.025

    authors: Zhao Y,Zhang Y,Wang S,Hua Z,Zhang J

    更新日期:2011-02-01 00:00:00

  • Effect of a collagen derived octapeptide on different steps of the platelet/collagen interaction.

    abstract::The interaction of platelets with collagen involves short aminoacid sequences which recur along the fibres. Platelet aggregation by collagen and serotonin release is inhibited by a synthetic octapeptide LYS-PRO-GLY-GLU- PRO-GLY-PRO-LYS- derived from type III collagen. In contrast, this octapeptide inhibits only weakly...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(83)90061-0

    authors: Karniguian A,Legrand YJ,Lefrancier P,Caen JP

    更新日期:1983-12-15 00:00:00

  • The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation.

    abstract::Bleeding events are a common adverse effect in oral anticoagulation that frequently depend on the duration and intensity of treatment. Major bleeding events, particularly intracerebral hemorrhages, are a serious complication in cases that require the rapid reversal of anticoagulation. Urgent correction of the coagulat...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/s0049-3848(99)00085-7

    authors: Pindur G,Mörsdorf S

    更新日期:1999-08-15 00:00:00

  • Accumulation of platelets as a key mechanism of human erection.

    abstract::In this study, the role of platelets in the human erectile response was assessed. Twenty patients with erectile dysfunction were studied by means of (111)In-oxine-platelets and blood pool imaging using 99mTc. Seventeen patients received intracavernously prostaglandin E1, and three patients received papaverine together...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0049-3848(98)00065-6

    authors: Rodrigues M,O'Grady J,Stackl W,Granegger S,Sinzinger H

    更新日期:1998-07-15 00:00:00

  • Outpatient management of pulmonary embolism.

    abstract::Despite clear potential benefits of outpatient care, most patients suffering from pulmonary embolism (PE) are currently hospitalized due to the fear of possible adverse events. Nevertheless, some teams have increased or envisage to increase outpatient treatment or early discharge. We performed a narrative systematic r...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2017.05.001

    authors: Roy PM,Moumneh T,Penaloza A,Sanchez O

    更新日期:2017-07-01 00:00:00

  • Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin.

    abstract::The lupus ratio (LR) test is a normalized ratio of the clotting times obtained with low and high phospholipid (PL) concentrations, where the test plasma is mixed 1:1 with normal pooled plasma (NP). As an integrated, automated, and computer-assisted assay, this principle has been applied to the dilute activated partial...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00420-0

    authors: Liestøl S,Jacobsen EM,Wisløff F

    更新日期:2002-01-15 00:00:00

  • eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population.

    abstract:INTRODUCTION:Nitric oxide (NO) plays an important role in the regulation of the cardiovascular system. It is produced by endothelial nitric oxide synthase (eNOS), which exhibits genetic polymorphisms. Although the clinically relevant polymorphism T(+IhI-786)C reduces eNOS-promoter activity, it is not clear whether circ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.09.003

    authors: Nagassaki S,Metzger IF,Souza-Costa DC,Marroni AS,Uzuelli JA,Tanus-Santos JE

    更新日期:2005-01-01 00:00:00

  • Laboratory evaluation of the Coasys® Plus C coagulation analyzer.

    abstract:INTRODUCTION:The Coasys® Plus C (Behnk Elektronik, distributed by Roche Diagnostics) is a coagulation analyzer for small to midsize clinical chemistry laboratories. We performed a laboratory evaluation. MATERIALS AND METHODS:After a familiarization period the dead volume, carry-over, capacity, within-assay reproducibi...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.02.004

    authors: de Bie P,Schornagel WJ,van den Dool EJ,Bakker B,van Dam W,Heckman M,Ağar C,Sturk A,Stroobants AK

    更新日期:2013-04-01 00:00:00

  • Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns.

    abstract:BACKGROUND:Whether antibodies directed to β2-Glycoprotein I (aβ2GPI) are responsible for LA activity is not well defined. However, in the absence of such antibodies the molecule responsible for LA phenomenon is unknown. OBJECTIVE:The aim of this study was the biochemical identification of the target antigen epitope of...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.11.003

    authors: Pengo V,Del Ross T,Ruffatti A,Bison E,Cattini MG,Pontara E,Testa S,Legnani C,Pozzi N,Peterle D,Acquasaliente L,De Filippis V,Denas G

    更新日期:2018-12-01 00:00:00

  • Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.

    abstract:BACKGROUND:The AMPLIFY trial found significantly lower major bleeding (MB) and similar recurrent venous thromboembolism (VTE) risks associated with apixaban vs warfarin among patients with VTE. OBJECTIVES:To compare MB, clinically-relevant non-major (CRNM) bleeding, and recurrent VTE risks among clinically-relevant su...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.11.039

    authors: Guo JD,Hlavacek P,Rosenblatt L,Keshishian A,Russ C,Mardekian J,Ferri M,Poretta T,Yuce H,McBane R

    更新日期:2020-12-08 00:00:00

  • Genetic prothrombotic risk factors in women with unexplained pregnancy loss.

    abstract:INTRODUCTION:Inherited thrombophilia has been associated with unexplained recurrent pregnancy loss (RPL) and stillbirth. This thrombotic tendency can manifest as thrombotic lesions in the placenta, and may lead to abortion and stillbirth. The aim of our case-control study was to investigate the prevalence of FVL and FI...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2005.06.005

    authors: Sottilotta G,Oriana V,Latella C,Luise F,Piromalli A,Ramirez F,Mammì C,Santoro R,Iannaccaro P,Muleo G,Lombardo VT

    更新日期:2006-01-01 00:00:00

  • Erik von Willebrand.

    abstract::In 1926, Erik von Willebrand, a Finnish physician, published the first manuscript describing a haemorrhagic disorder in people who were living on the Aland islands off the coast of Finland. This disorder is now known by the name of its discoverer. Since this early observation, von Willebrand disease has been extensive...

    journal_title:Thrombosis research

    pub_type: 传,历史文章,杂志文章

    doi:10.1016/j.thromres.2007.03.010

    authors: Berntorp E

    更新日期:2007-01-01 00:00:00

  • Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

    abstract:BACKGROUND:Although patients undergoing coronary stenting routinely receive dual antiplatelet treatment to reduce the risk of stent thrombosis, this undesired event still occurs. A suboptimal response to clopidogrel treatment (low responders) has been suggested to contribute to stent thrombosis. In the present study, p...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.07.007

    authors: Angiolillo DJ,Fernandez-Ortiz A,Bernardo E,Ramírez C,Barrera-Ramirez C,Sabaté M,Hernández R,Moreno R,Escaned J,Alfonso F,Bañuelos C,Costa MA,Bass TA,Macaya C

    更新日期:2005-01-01 00:00:00

  • Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.

    abstract:INTRODUCTION:The contact system proteins factor XII (FXII), prekallikrein (PK) and high molecular weight kininogen (HK) have roles in coagulation, fibrinolysis, thrombin-induced platelet activation, cell adhesion and angeogenisis. It has been suggested that inherited or acquired deficiencies of these proteins may be ri...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.thromres.2004.05.005

    authors: Gallimore MJ,Harris SL,Jones DW,Winter M

    更新日期:2004-01-01 00:00:00

  • Endogenous forms of fibrinogen in Hep G2 cells.

    abstract::The three polypeptide chains of fibrinogen, A alpha, B beta and gamma chain, are synthesized on separate polysomes. Fully formed fibrinogen is a six chain, disulfide-linked, dimeric molecule with a molecular weight of 340kDa. Previous pulse-chase studies with L-35 S methionine using the human hepatocellular carcinoma ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90290-8

    authors: Yu S,Kong V,Kudryk B,Redman C

    更新日期:1987-04-15 00:00:00

  • Development of an ELISA for the quantification of fibrin in canine tumours.

    abstract::Fibrin is found in most solid tumours, and there is speculation regarding its role in tumour invasion and metastasis. An assay to quantitate fibrin levels in tissues would be a useful preliminary tool in assessing the above. Such an assay to quantitatively detect levels of fibrin in various types of canine tumour was ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00054-7

    authors: Raut S,McEvoy F,Gaffney PJ

    更新日期:1999-10-01 00:00:00

  • An ultrastructural study of Porphyromonas gingivalis-induced platelet aggregation.

    abstract::One of the major pathogens of periodontitis, Porphyromonas gingivalis (P. gingivalis), has the ability to aggregate human platelets. To investigate the interaction between P. gingivalis and human platelets in platelet rich plasma (PRP), platelet aggregation was measured by an aggregometer based on laser light scatteri...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.03.011

    authors: Li X,Iwai T,Nakamura H,Inoue Y,Chen Y,Umeda M,Suzuki H

    更新日期:2008-01-01 00:00:00

  • The activation of plasminogen by T-PA-PAI-1 complex in the absence of fibrin.

    abstract::The activity of tissue plasminogen activator-plasminogen activator inhibitor-1 (t-PA-PAI-1) complex to convert plasminogen to plasmin was examined by using fibrin autography and casein zymography where plasminogen was added or removed for casein layer. Fibrin autography was more sensitive to the activity of t-PA even ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(91)90279-6

    authors: Takada Y,Takada A

    更新日期:1991-07-01 00:00:00

  • Thrombomodulin and ristocetincofactor in homocystinuria: a study in two siblings.

    abstract::Homocystinuria due to cystathionine-beta-synthase deficiency (CBS-def-HOCY) initially often presents with vascular disorders, e.g. thromboembolic events. The measurement of vascular endothelial markers in plasma could help to assess endothelial damage. We determined von Willebrand factor (measured as Ristocetincofacto...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(95)90867-f

    authors: Schienle HW,Seitz R,Nawroth P,Rohner I,Lerch L,Krumpholz B,Krauss G,Fowler B,Baumgartner R,Willenbockel U

    更新日期:1995-01-01 00:00:00

  • Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.

    abstract::We have investigated the role of platelet activating factor (PAF) in the pathogenesis of a murine model of traumatic shock using WEB 2086, a specific antagonist of PAF. WEB 2086 (0.5 mg/kg) significantly reversed the decrease in mean arterial blood pressure (MABP) induced by PAF (0.3 micrograms/kg) in anesthetized rat...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(89)90107-2

    authors: Stahl GL,Bitterman H,Lefer AM

    更新日期:1989-02-01 00:00:00

  • Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.

    abstract::There is growing evidence on the superior efficacy and safety of low molecular weight heparins (LMWHs) over unfractionated heparin (UFH) for the treatment of both venous and arterial thromboembolism. Heparin exerts its function by potentiating antithrombin and by mobilizing tissue factor pathway inhibitor (TFPI) into ...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0049-3848(98)00079-6

    authors: Hansen JB,Sandset PM

    更新日期:1998-08-15 00:00:00

  • Thrombin generation post elective caesarean section: effect of low molecular weight heparin.

    abstract:INTRODUCTION:Caesarean section (CS) is a significant risk factor for venous thromboembolism.. Low molecular weight heparin (LMWH) is commonly used for thromboprophylaxis post emergency caesarean delivery. However, no consensus exists regarding LMWH thromboprophylaxis following elective caesarean section. Measures of th...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.thromres.2012.01.008

    authors: Ismail SK,Norris L,Muttukrishna S,Higgins JR

    更新日期:2012-11-01 00:00:00

  • Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal.

    abstract:INTRODUCTION:Venous thromboembolism (VTE) prophylaxis guidelines for non-surgical patients recommend VTE- and bleeding risk assessment to guide prophylactic strategies. These recommendations differ between guidelines and implementation is suboptimal. Assessing a guideline's implementability characteristics helps predic...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.05.028

    authors: Moesker MJ,Damen NL,Volmeijer EE,Dreesens D,de Loos EM,Vink R,Coppens M,Kruip MJ,Meijer K,Langelaan M,de Bruijne MC,Wagner C

    更新日期:2018-08-01 00:00:00

  • Lonofibrase, a novel alpha-fibrinogenase from Lonomia obliqua caterpillars.

    abstract::Envenomation caused by Lonomia obliqua caterpillars is an increasing problem in Southern Brazil. The clinical profile is characterized by a profound hemorrhagic disorder. In the present study, we describe the characterization of a fibrin(ogen)olytic factor (lonofibrase) isolated from a venomous secretion of the caterp...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.01.012

    authors: Pinto AF,Dobrovolski R,Veiga AB,Guimarães JA

    更新日期:2004-01-01 00:00:00